Description: Innate Pharma SA is a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. Its products include immunotherapy drugs and monoclonal antibodies. The Immunotherapy drugs are designated for cancer and inflammatory diseases. The Monoclonal antibodies targets receptors and pathways controlling the activation of innate immunity cells. The company was founded by Hervé Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié and François Romagné on September 15, 1999 and is headquartered in Marseille, France.
Home Page: www.innate-pharma.com
IPHA Technical Analysis
117, Avenue de Luminy
Marseille,
13009
France
Phone:
33 4 30 30 30 30
Officers
| Name | Title |
|---|---|
| Dr. Mondher Mahjoubi M.D. | Chairman of Exec. Board & CEO |
| Mr. Yannis Morel Ph.D. | Exec. VP of Product Portfolio Strategy & Bus. Devel. and Member of Exec. Board |
| Dr. Herve Brailly | Co-Founder & Chairman of Supervisory Board |
| Dr. François Romagné Ph.D. | Founder |
| Mr. Eric Vivier D.V.M., M.B.A., Ph.D. | Founder, Sr. VP & Chief Scientific Officer |
| Dr. Marc Bonneville Ph.D. | Founder |
| Mr. Jean Jacques Fournié Ph.D. | Founder |
| Mr. Alessandro Moretta M.D., Ph.D. | Founder |
| Mr. Frederic Lombard M.B.A. | Sr. VP & CFO |
| Ms. Odile Belzunce | VP of Compliance & Operations |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.3445 |
| Price-to-Sales TTM: | 3.0969 |
| IPO Date: | 2019-10-17 |
| Fiscal Year End: | December |
| Full Time Employees: | 213 |